Main > ONCOLOGY (**) > Leukemia>Myeloid>Chronic>Ph+ * > Treatment > Co.: CH. N. Brand Nilotinib > Mechanism: Bcr-Abl Tyrosine Kinase

Inhibition


Mechanism: Bcr-Abl Tyrosine Kinase's products
This section has no products